Stryker Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Kevin A. Lobo
- Full Time Employees
- 56,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1941 Stryker Way Portage MI United States of America 49002
- IPO Date
- Mar 17, 1980
- CIK
- 0000310764
- Website
- stryker.com
- Similar Companies
- Business
- Stryker Corporation (NYSE: SYK) develops, manufactures, and markets medical technologies, including orthopedic implants and instruments; surgical equipment and navigation systems; endoscopic and communications products; and patient handling and emergency medical equipment. The company offers its Mako robotic-arm assisted surgery platform for orthopedic procedures; Triathlon and Trident hip and knee systems; Gamma3 and T2 intramedullary nailing systems; and Ceros and Variax distal fixation systems, among other specialized devices for joint reconstruction, trauma and extremities, and spine care. Stryker provides interventional devices, including embolic products and guidewires, along with neurotechnology and spine products such as Vizor vision systems and SurgiCount safety sponges; it also delivers solutions for operating room integration and capital equipment. Founded in 1941 and headquartered in Kalamazoo, Michigan, the company operates globally across the Americas, Europe, Asia-Pacific, and other regions, serving hospitals, ambulatory surgery centers, and healthcare providers in the medtech industry. In recent developments, Stryker completed the acquisition of Artelon AB in September 2024, enhancing its sports medicine portfolio with advanced biomaterials for soft tissue regeneration. The company also acquired Wright Medical Group N.V. in 2022, bolstering its extremity reconstruction offerings, and continues to expand through strategic investments, including a new manufacturing facility in Ireland to support European growth. Additionally, Stryker launched the next-generation Mako Total Knee 2.0 application and advanced its Blue Seal bipolar sealer technology, reflecting ongoing innovation in robotics and surgical efficiency amid robust demand in orthopedics and neurotechnology segments.
Company News
Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
Stryker Launches FDA-Cleared Apple Vision Pro Surgical App
Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio
Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center
Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering
Caisse de depot et placement du Quebec Makes New Investment in Stryker Corporation $SYK
Stryker Corporation $SYK Shares Sold by BNP Paribas
Beacon Pointe Advisors LLC Purchases Shares of 40,773 Stryker Corporation $SYK
PBH vs. SYK: Which Stock Is the Better Value Option?
4,876 Shares in Stryker Corporation $SYK Acquired by Ancora Advisors LLC
Stryker to participate in the 2026 Wells Fargo Healthcare Conference
Do Options Traders Know Something About Stryker Stock We Don't?
Ally Financial Inc. Invests $4.09 Million in Stryker Corporation $SYK
Amazon.com (NASDAQ:AMZN) Stock Bought Rep. Thomas H. Kean, Jr.
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Stryker Corporation $SYK Stock Position Reduced by Bank of New York Mellon Corp
Advisors Preferred LLC Buys New Position in Stryker Corporation $SYK
B. Metzler seel. Sohn & Co. AG Makes New Investment in Stryker Corporation $SYK
6,155 Shares in Stryker Corporation $SYK Acquired by AlpenGlobal Capital LLC
Advisors Capital Management LLC Buys Shares of 89,485 Stryker Corporation $SYK